PHA-848125 is a cyclin dependent kinase (CDK) inhibitor. Oral PHA-848125 showed antitumor activity via dual targeting of cyclin-dependent kinase and tropomyosin receptor kinase families in human carcinoma cell and xenografted mouse model of carcinoma. Molecular Formula: C25H32N8O Molecular Weight: 460.57 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
460.57
CAS Number:
[802539-81-7]
* VAT and and shipping costs not included. Errors and price changes excepted